These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22217582)

  • 1. Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome.
    Hirst CL; Ingram G; Pickersgill TP; Robertson NP
    Mult Scler; 2012 Aug; 18(8):1152-8. PubMed ID: 22217582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G; Napoletano R; Esposito A
    Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L; Kragt JJ; Polman CH; Uitdehaag BM
    Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
    Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
    Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of multiple sclerosis in Lebanon.
    Yamout B; Itani S; Arabi A; Hamzeh D; Yaghi S
    Int J Neurosci; 2010 Mar; 120(3):206-10. PubMed ID: 20374088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.
    Zamboni P; Galeotti R; Menegatti E; Malagoni AM; Gianesini S; Bartolomei I; Mascoli F; Salvi F
    J Vasc Surg; 2009 Dec; 50(6):1348-58.e1-3. PubMed ID: 19958985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
    van Winsen LM; Kragt JJ; Hoogervorst EL; Polman CH; Uitdehaag BM
    Mult Scler; 2010 May; 16(5):604-10. PubMed ID: 20086019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
    Leone MA; Bonissoni S; Collimedaglia L; Tesser F; Calzoni S; Stecco A; Naldi P; Monaco F
    Mult Scler; 2008 May; 14(4):485-93. PubMed ID: 18208889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
    Gijbels D; Alders G; Van Hoof E; Charlier C; Roelants M; Broekmans T; Eijnde BO; Feys P
    Mult Scler; 2010 May; 16(5):618-26. PubMed ID: 20207785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis.
    Kierkegaard M; Einarsson U; Gottberg K; von Koch L; Holmqvist LW
    Mult Scler; 2012 May; 18(5):639-46. PubMed ID: 21982871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting accidental falls in people with multiple sclerosis -- a longitudinal study.
    Nilsagård Y; Lundholm C; Denison E; Gunnarsson LG
    Clin Rehabil; 2009 Mar; 23(3):259-69. PubMed ID: 19218300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.